Steven Cohen's BBNX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 987,351 shares of Beta Bionics, Inc. (BBNX) worth $30.08 M, representing 0.03% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in BBNX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 987,351 shares. Largest reduction occurred in Q2 2025, reducing 364,329 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Beta Bionics (BBNX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Beta Bionics (BBNX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +987,351 | New Buy | 987,351 | $30.47 |
| Q2 2025 | -364,329 | Sold Out | 0 | $0.00 |
| Q1 2025 | +364,329 | New Buy | 364,329 | $12.24 |
Steven Cohen's Beta Bionics Investment FAQs
Steven Cohen first purchased Beta Bionics, Inc. (BBNX) in Q1 2025, acquiring 364,329 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Beta Bionics, Inc. (BBNX) for 3 quarters since Q1 2025.
Steven Cohen's largest addition to Beta Bionics, Inc. (BBNX) was in Q4 2025, adding 987,351 shares worth $30.08 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 987,351 shares of Beta Bionics, Inc. (BBNX), valued at approximately $30.08 M.
As of the Q4 2025 filing, Beta Bionics, Inc. (BBNX) represents approximately 0.03% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Beta Bionics, Inc. (BBNX) was 987,351 shares, as reported at the end of Q4 2025.